相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update
Valerie Voon et al.
LANCET NEUROLOGY (2017)
Changes in Quality of Life in Parkinson's Disease: How Large Must They Be to Be Relevant?
Krisztina Horvath et al.
NEUROEPIDEMIOLOGY (2017)
Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's Disease
Yoshihide Sehara et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2017)
Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial
Agnieszka Ciesielska et al.
PLOS ONE (2017)
Optimizing extended-release carbidopa/levodopa in Parkinson disease Consensus on conversion from standard therapy
Alberto J. Espay et al.
NEUROLOGY-CLINICAL PRACTICE (2017)
Transduction of antigen-presenting cells in the brain by AAV9 warrants caution in preclinical studies
John Forsayeth et al.
MOLECULAR THERAPY (2015)
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised
Richard Gray et al.
LANCET (2014)
Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Efficacy
Raymond T. Bartus et al.
MOLECULAR THERAPY (2014)
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease
Jeffrey H. Kordower et al.
BRAIN (2013)
Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
Gabriele Mittermeyer et al.
HUMAN GENE THERAPY (2012)
Novel Platform for MRI-Guided Convection-Enhanced Delivery of Therapeutics: Preclinical Validation in Nonhuman Primate Brain
R. Mark Richardson et al.
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY (2011)
The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale
Lisa M. Shulman et al.
ARCHIVES OF NEUROLOGY (2010)
Effects of a Dopamine Agonist on the Pharmacodynamics of Levodopa in Parkinson Disease
Matthew A. Brodsky et al.
ARCHIVES OF NEUROLOGY (2010)
Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors
Xiaomin Su et al.
MOLECULAR THERAPY (2010)
Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
Piotr Hadaczek et al.
MOLECULAR THERAPY (2010)
A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease
Shin-ichi Muramatsu et al.
MOLECULAR THERAPY (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
C. W. Christine et al.
NEUROLOGY (2009)
Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC
Krystof S. Bankiewicz et al.
MOLECULAR THERAPY (2006)
A dose-ranging study of AAV-hAADC therapy in parkinsonian monkeys
John R. Forsayeth et al.
MOLECULAR THERAPY (2006)
Pharmacokinetic and pharmacodynamic changes during the first four years of levodopa treatment in Parkinson's disease
PLS Chan et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2005)
Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats
R Sánchez-Pernaute et al.
MOLECULAR THERAPY (2001)
Convection-enhanced delivery of AAV vector in parkinsonian monkeys;: In vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach
KS Bankiewicz et al.
EXPERIMENTAL NEUROLOGY (2000)
A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia
RA Hauser et al.
CLINICAL NEUROPHARMACOLOGY (2000)
分享论文
